EPO and neoplasm: In a mouse tumor-bearing model, hemoglobin concentration and hematocrit gradually decrease as the tumor progresses, and the hypoxic environment and tumor-induced anemia increase blood EPO concentration (13), accompanied by the aggregation of CECs in the spleen and liver other than in the bone marrow (12–14).